These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 15385816)

  • 21. Improvement in human decay accelerating factor transgenic porcine kidney xenograft rejection with intravenous administration of gas914, a polymeric form of alphaGAL.
    Zhong R; Luo Y; Yang H; Garcia B; Ghanekar A; Luke P; Chakrabarti S; Lajoie G; Phillips MJ; Katopodis AG; Duthaler RO; Cattral M; Wall W; Jevnikar A; Bailey M; Levy GA; Grant DR
    Transplantation; 2003 Jan; 75(1):10-9. PubMed ID: 12544864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular participation in delayed xenograft rejection of hCD55 transgenic pig hearts by baboons.
    Ashton-Chess J; Roussel JC; Manez R; Ruiz C; Moreau A; Cozzi E; Minault D; Soulillou JP; Blancho G
    Xenotransplantation; 2003 Sep; 10(5):446-53. PubMed ID: 12950987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mean xenograft survival of 14.6 days in a small group of hDAF-transgenic pig hearts transplanted orthotopically into baboons.
    Brenner P; Schmoeckel M; Wimmer C; Eder V; Rucker A; Felbinger T; Uchita S; Hinz M; Brandl U; Meiser B; Reichenspurner H; Hammer C; Reichart B
    Transplant Proc; 2005; 37(1):472-6. PubMed ID: 15808680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human DAF on pig cells protects against human and non-human primate sera cytotoxicity mediated by exogenous or endogenous complement, as determined by flow cytometry.
    Díaz-Román TM; Mañez R; López-Pelaez E; Centeno A; Moscoso I; Pértegaz S; Doménech N
    Transpl Immunol; 2006 Aug; 16(2):125-30. PubMed ID: 16860716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Failure to deplete anti-Galalpha1-3Gal antibodies after pig-to-baboon organ xenotransplantation by immunoaffinity columns containing multiple Galalpha1-3Gal oligosaccharides.
    Mañez R; Domenech N; Centeno A; Lopez-Pelaez E; Crespo F; Juffe A; Duthaler RO; Katopodis AG
    Xenotransplantation; 2004 Sep; 11(5):408-15. PubMed ID: 15303977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-non-Gal porcine endothelial cell antibodies in acute humoral xenograft rejection of hDAF-transgenic porcine hearts in cynomolgus monkeys.
    Lam TT; Paniagua R; Shivaram G; Schuurman HJ; Borie DC; Morris RE
    Xenotransplantation; 2004 Nov; 11(6):531-5. PubMed ID: 15479463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Xenotransplantation of human decay accelerating factor transgenic porcine kidney to non-human primates: 4 years experience at a Canadian center.
    Garcia B; Sun HT; Yang HJ; Chen G; Zhong R
    Transplant Proc; 2004; 36(6):1714-6. PubMed ID: 15350460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coagulation cascade activation triggers early failure of pig hearts expressing human complement regulatory genes.
    Wu G; Pfeiffer S; Schröder C; Zhang T; Nguyen BN; Kelishadi S; Atkinson JB; Schuurman HJ; White DJ; Azimzadeh AM; Pierson RN
    Xenotransplantation; 2007 Jan; 14(1):34-47. PubMed ID: 17214703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Splenectomy improves survival of HDAF transgenic pig kidneys in primates.
    Schmoeckel M; Bhatti FN; Zaidi A; Cozzi E; Chavez G; Wallwork J; White DJ; Friend PJ
    Transplant Proc; 1999; 31(1-2):961. PubMed ID: 10083427
    [No Abstract]   [Full Text] [Related]  

  • 30. Incidence of hyperacute rejection in pig-to-primate transplantation using organs from hDAF-transgenic donors.
    Schuurman HJ; Pino-Chavez G; Phillips MJ; Thomas L; White DJ; Cozzi E
    Transplantation; 2002 Apr; 73(7):1146-51. PubMed ID: 11965048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Xenotransplantation of hDAF-transgenic swine hearts].
    Schmoeckel M; Cozzi E; Chavez G; Dunning JJ; Wallwork J; White DJ
    Zentralbl Chir; 1999; 124(7):604-8. PubMed ID: 10474873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical xenotransplantion--how close are we?
    Cooper DK
    Lancet; 2003 Aug; 362(9383):557-9. PubMed ID: 12932390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of hyperacute rejection by human decay accelerating factor in xenogeneic perfused working hearts.
    Schmoeckel M; Nollert G; Shahmohammadi M; Young VK; Chavez G; Kasper-König W; White DJ; Müller-Höcker J; Arendt RM; Wilbert-Lampen U; Hammer C; Reichart B
    Transplantation; 1996 Sep; 62(6):729-34. PubMed ID: 8824468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combining the hDAF transgene with the GP IIb/IIIa inhibitor tirofiban improves heart performance and reduces myocardial damage following hyperacute rejection in an ex vivo perfusion model.
    Brandl U; Erhardt M; Joeckle H; Michel S; Brenner P; Bittmann I; Roessle M; Mordstein V; Hammer C; Schmoeckel M; Reichart B
    Transplant Proc; 2005; 37(1):491-2. PubMed ID: 15808686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment with rabbit antithymocyte serum permits a cyclophosphamide-free approach to prevention of hDAF transgenic porcine kidney xenograft rejection in baboons.
    Ghanekar A; Lajoie G; Luo Y; Yang H; Choi J; Garcia B; Greig PD; Cattral MS; Cole EH; Phillips MJ; Cardella CJ; Levy GA; Zhong R; Grant DR
    Transplant Proc; 2001; 33(7-8):3849-50. PubMed ID: 11750638
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunopathology of an hDAF transgenic pig model liver xenotransplant into a primate.
    Sanchez A; Ramirez P; Pino G; Chavez R; Majado M; Munitiz V; Muñoz A; Palenciano CG; Yelamos J; Rodriguez-Gago M; Pons JA; Parrilla P
    Transplant Proc; 2003 Aug; 35(5):2041-2. PubMed ID: 12962888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of anti-non-Gal antibodies in the development of acute humoral xenograft rejection of hDAF transgenic porcine kidneys in baboons receiving anti-Gal antibody neutralization therapy.
    Chen G; Sun H; Yang H; Kubelik D; Garcia B; Luo Y; Xiang Y; Qian A; Copeman L; Liu W; Cardella CJ; Wang W; Xiong Y; Wall W; White DJ; Zhong R
    Transplantation; 2006 Jan; 81(2):273-83. PubMed ID: 16436972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Life-supporting pig-to-baboon heart xenotransplantation.
    Waterworth PD; Dunning J; Tolan M; Cozzi E; Langford G; Chavez G; White D; Wallwork J
    J Heart Lung Transplant; 1998 Dec; 17(12):1201-7. PubMed ID: 9883761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of pigs transgenic for human decay-accelerating factor.
    Cozzi E; Tucker AW; Langford GA; Pino-Chavez G; Wright L; O'Connell MJ; Young VJ; Lancaster R; McLaughlin M; Hunt K; Bordin MC; White DJ
    Transplantation; 1997 Nov; 64(10):1383-92. PubMed ID: 9392299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A recombinant soluble chimeric complement inhibitor composed of human CD46 and CD55 reduces acute cardiac tissue injury in models of pig-to-human heart transplantation.
    Kroshus TJ; Salerno CT; Yeh CG; Higgins PJ; Bolman RM; Dalmasso AP
    Transplantation; 2000 Jun; 69(11):2282-9. PubMed ID: 10868627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.